HGSI---another "me-too" interferon! Wooo-hoooo, comparable with Pegasys, nothing to get excited about there, hmmm, single dose advantage, might be a hard compound to sell to Wall Street given the interferon market is already well-established with SGP and Roche controlling it. Good Luck to HGSI, have they ever had a candidate make it to market?
Market Data 
Markets 
AI
